Plavix Patent Infringement Trial Set For Jan. 22
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi/Bristol demonstrated that Apotex patent invalidity defense "lacks substantial merit," according to a court ruling granting a preliminary injunction blocking generics.